Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi‐eligible countries

The human papillomavirus (HPV) vaccines may provide some level of cross‐protection against high‐risk HPV genotypes not directly targeted by the vaccines. We evaluated the long‐term health and economic impacts of routine HPV vaccination using either the nonavalent HPV vaccine or the bivalent HPV vacc...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	International journal of cancer Ročník 148; číslo 4; s. 932 - 940
Hlavní autori:	Burger, Emily A., Portnoy, Allison, Campos, Nicole G., Sy, Stephen, Regan, Catherine, Kim, Jane J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Hoboken, USA John Wiley & Sons, Inc 15.02.2021 Wiley Subscription Services, Inc
Predmet:	Cancer Cancer vaccines Cervical cancer Cervix GDP Genotypes Gross Domestic Product Human papillomavirus Immunization low‐ and middle‐income countries Medical research Vaccines low- and middle-income countries vaccines cervical cancer human papillomavirus
ISSN:	0020-7136, 1097-0215, 1097-0215
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!